Skip to content

En español

Author Archive

How Breast Cancer Drugs Are Developed: The Bazedoxifene Story

By on August 13th, 2013 Categories: Research News, Treatment & Side Effects

Many of you may have read a news story about bazedoxifene (BZA), a SERM (selective estrogen receptor modulator) approved in Europe to treat osteoporosis that has been shown to stop the growth of hormone-receptor-positive breast cancer cells, even in cancers that had become resistant to tamoxifen or the aromatase inhibitors.

Women in this situation are wondering if they can try BZA – either prescribed by …

Back to top is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information. 120 East Lancaster Avenue, Suite 201 Ardmore, PA 19003

© 2015 - All rights reserved.